dr. Harry Pinson (MD)
CRIG member
Neurosurgeon (UZ Ghent)
Principal Investigator: prof. Tom Boterberg (MD, PhD)
Research focus
- Clinical research in glioma care with focus on outcome prediction
- Epidemiology in glioma
- Biomarkers in the diagnosis and follow-up of glioblastoma
Biography
Harry Pinson graduated at Ghent University in 2017 and completed his neurosurgical training in 2023. After this, he pursued a fellowship in skull base neurosurgery at the Lariboisière Hospital in Paris. During his training, he developed a special interest in glioma care and clinical research in neuro-oncology.
Key publications
- Epidemiology and survival in adult-type diffuse glioma in Belgium during the molecular era. Neuro-Oncology, 2024. (PMID: 37651614).
- Weak MGMT gene promoter methylation confers a clinically significant survival benefit in patients with newly diagnosed glioblastoma: a retrospective cohort study. Journal of Neuro-Oncology, 2020. (PMID: 000495020400001).
- Subventricular zone contacting glioblastoma: tumor size, molecular biological factors and patient survival. Acta Oncologica, 2020 (PMID: 000549030500001).
- Partial resection offers an overall survival benefit over biopsy in MGMT-unmethylated IDH-wildtype glioblastoma patients. Surgical Oncology, 2020 (PMID: 000600212300012).
- Survival impact of incidental subventricular zone irradiation in IDH-wildtype glioblastoma. Acta Oncologica, 2021 (PMID: 000626930700001).
Contact & links
- Harry Pinson is interested to receive invitations for presentations or talks